124 related articles for article (PubMed ID: 17545722)
1. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients.
Rosignoli G; Cranage A; Burton C; Nelson M; Steel A; Gazzard B; Gotch F; Imami N
AIDS; 2007 Jun; 21(10):1379-81. PubMed ID: 17545722
[TBL] [Abstract][Full Text] [Related]
2. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
[TBL] [Abstract][Full Text] [Related]
3. Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatment.
Grabmeier-Pfistershammer K; Steinberger P; Rieger A; Leitner J; Kohrgruber N
J Acquir Immune Defic Syndr; 2011 Feb; 56(2):118-24. PubMed ID: 20980914
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy.
Benlahrech A; Yasmin A; Westrop SJ; Coleman A; Herasimtschuk A; Page E; Kelleher P; Gotch F; Imami N; Patterson S
Clin Exp Immunol; 2012 Nov; 170(2):212-21. PubMed ID: 23039892
[TBL] [Abstract][Full Text] [Related]
5. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
Pettersen FO; Taskén K; Kvale D
Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
[TBL] [Abstract][Full Text] [Related]
6. Study of T cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART.
Shou C; Weng N; Jin Y; Feng L; Jin C; Hoextermann S; Potthoff A; Skaletz-Rorowski A; Brockmeyer NH; Wu N
Eur J Med Res; 2011 Nov; 16(11):473-9. PubMed ID: 22027639
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of PD-1- and PD-L1- positive T CD3
Nowicka D; Grywalska E; Surdacka A; Grafka A; Roliński J
Microb Pathog; 2019 Jan; 126():85-91. PubMed ID: 30342909
[TBL] [Abstract][Full Text] [Related]
8. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
[TBL] [Abstract][Full Text] [Related]
9. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
[TBL] [Abstract][Full Text] [Related]
10. Programmed death 1 receptor changes ex vivo in HIV-infected adults following initiation of highly active antiretroviral therapy.
Spitsin S; Tustin NB; Riedel E; Tustin R; Murray JB; Peck LM; Khan M; Quinn J; Douglas SD
Clin Vaccine Immunol; 2012 May; 19(5):752-6. PubMed ID: 22441393
[TBL] [Abstract][Full Text] [Related]
11. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
13. Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway.
Bowers NL; Helton ES; Huijbregts RP; Goepfert PA; Heath SL; Hel Z
PLoS Pathog; 2014 Mar; 10(3):e1003993. PubMed ID: 24626392
[TBL] [Abstract][Full Text] [Related]
14. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.
Tendeiro R; Foxall RB; Baptista AP; Pinto F; Soares RS; Cavaleiro R; Valadas E; Gomes P; Victorino RM; Sousa AE
AIDS; 2012 Jun; 26(9):1065-71. PubMed ID: 22441249
[TBL] [Abstract][Full Text] [Related]
15. Short communication: enhanced CD8+ T cell apoptosis in HIV-infected adolescents with virologic failure on protease inhibitor-based therapy.
Zuo J; Church J; Belzer M; Kitchen C; Ank B; Schmid I; Krogstad P
AIDS Res Hum Retroviruses; 2010 Jun; 26(6):681-4. PubMed ID: 20507209
[TBL] [Abstract][Full Text] [Related]
16. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
[TBL] [Abstract][Full Text] [Related]
17. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
[TBL] [Abstract][Full Text] [Related]
18. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
[TBL] [Abstract][Full Text] [Related]
19. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.
Leng Q; Bentwich Z; Magen E; Kalinkovich A; Borkow G
AIDS; 2002 Mar; 16(4):519-29. PubMed ID: 11872994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
